Tae‐You Kim - Researcher Profile | RDL Research Database

Publications

2 shown

Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma

Richard S. Finn , Shukui Qin , Masafumi Ikeda +18 more

In patients with unresectable hepatocellular carcinoma, atezolizumab combined with bevacizumab resulted in better overall and progression-free survival outcomes than sorafenib. ...

2020 New England Journal of Medicine 6464 citations

Predictive and Prognostic Impact of Epidermal Growth Factor Receptor Mutation in Non–Small-Cell Lung Cancer Patients Treated With Gefitinib

Sae‐Won Han , Tae‐You Kim , Pil Gyu Hwang +13 more

Purpose This study was undertaken to investigate the effects of epidermal growth factor receptor (EGFR) mutation and its downstream signaling on response and survival in non–sma...

2005 Journal of Clinical Oncology 775 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 7,239
Institution: New Generation University College

External Links

Google Scholar

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.